KOTAKBANK vs SHUKRAPHAR: Stock Comparison
Head-to-head financial and trading comparison between Kotak Mahindra Bank Limited (KOTAKBANK) and Shukra Pharmaceuticals Limited (SHUKRAPHAR) in the Cross-Sector Peers sector.
KOTAKBANK
NSE: KOTAKBANKSHUKRAPHAR
NSE: SHUKRAPHARKey Metrics Comparison Table
| Metric | KOTAKBANK | SHUKRAPHAR | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹441.00 | ₹66.94 | — |
| 1-Year Price Return | +16.3% | +61.61% | SHUKRAPHAR (45.31% higher) |
| 52-Week High | ₹441.00 | ₹72.58 | — |
| 52-Week Low | ₹370.10 | ₹41.42 | — |
| 30-Day Annualized Volatility | 20.67% | 64.68% | KOTAKBANK (Steadier) |
| 30-Day Average Daily Volume | 19,061,203 | 6,592,919 | KOTAKBANK (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between KOTAKBANK and SHUKRAPHAR, which stock gave better returns over the last year?
SHUKRAPHAR has outperformed KOTAKBANK over the past 12 months with a gain of 61.61% compared to 16.3%.
Which stock is less volatile: KOTAKBANK or SHUKRAPHAR?
KOTAKBANK demonstrated lower price volatility (20.67% annualized) compared to SHUKRAPHAR (64.68%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of KOTAKBANK vs SHUKRAPHAR?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are KOTAKBANK and SHUKRAPHAR direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.